Buqitongluo Granule

also known as BQTL granules · BuqiTongluo

Developed for: diabetic polyneuropathy · intermediate coronary syndrome · ischemic stroke
Investigated by: Affiliated Hospital of Changchun University of Chinese Medicine · Affiliated Hospital of Shandong University of Traditional Chinese Medicine · Beijing Chuanglikechuang Medical Technology Development Co., Ltd. · Chengdu University of Traditional Chinese Medicine · Dongzhimen Hospital, Beijing · First Affiliated Hospital of Guangxi Medical University
+12 more
· First Affiliated Hospital of Heilongjiang Chinese Medicine University · Hunan Academy of Traditional Chinese Medicine Affiliated Hospital · Jiangbin Hospital of Guangxi Zhuang Autonomous Region · Rizhao Hospital of Traditional Chinese Medicine · Second Affiliated Hospital of Heilongjiang University of Chinese Medicine · Shaanxi Buchang Pharmaceuticals Co., Ltd. · Shanghai Youningwei Biotechnology Co., Ltd. · The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine · The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine · The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine · Wuhan Third Hospital · Wuhan Zhizhi Medical Technology Co., Ltd.

today NCT04408261 · Ph 2

202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT04408261	Jul 2020 → Dec 2022	diabetic polyneuropathy, intermediate coronary syndrome, ischemic stroke	Dongzhimen Hospital, Beijing	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Buqitongluo Granule	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04408261 ↗
Known as	BQTL granules	“BuqiTongluo (BQTL) granules are herbal phenotypic drugs for Qi deficiency and blood stasis (QDBS) syndrome.” PMID 34733163 ↗ Oct 2021
Known as	BuqiTongluo	“BuqiTongluo (BQTL) granules are herbal phenotypic drugs for Qi deficiency and blood stasis (QDBS) syndrome.” PMID 34733163 ↗ Oct 2021
Modality	Traditional medicine (herbal / TCM)	“BuqiTongluo (BQTL) granules are herbal phenotypic drugs for Qi deficiency and blood stasis (QDBS) syndrome.” PMID 34733163 ↗ Oct 2021
Route	Oral	“administered orally” NCT04408261 ↗